MedTrace Logo

Probiotic Supplements in Chronic Kidney Disease

NCT05359094 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-07-23

No results posted yet for this study

Summary

This research will investigate the effect of oral probiotic supplements on renal function, uremic toxins inflammatory response, nutrition status, gastrointestinal symptoms, and QoL with Chronic kidney disease.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

Placebo (Microcrystalline α-cellulose) supplement with a Plant-Dominant Low-Protein Diet

DIETARY_SUPPLEMENT

Probiotics

Probiotics(Pediococcus acidilactici GKA4) supplement with a Plant-Dominant Low-Protein Diet

Sponsors & Collaborators

  • Grape King Bio Ltd.

    collaborator INDUSTRY

  • Taichung Veterans General Hospital

    lead OTHER

Principal Investigators

  • Cheng-Hsu Chen, MDPHD · Division of Nephrology in Taichung Veterans General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-08-08
Completion
2024-07-15

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05359094 on ClinicalTrials.gov